875 related articles for article (PubMed ID: 25795074)
1. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
[TBL] [Abstract][Full Text] [Related]
2. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
[TBL] [Abstract][Full Text] [Related]
3. Serum Fractalkines and Cardiovascular Outcomes in the CRIC Study Cohort.
Yang P; Xu G
Am J Kidney Dis; 2016 Feb; 67(2):342. PubMed ID: 26802332
[No Abstract] [Full Text] [Related]
4. In Reply to 'Serum Fractalkines and Cardiovascular Outcomes in the CRIC Study Cohort'.
Shah R
Am J Kidney Dis; 2016 Feb; 67(2):342. PubMed ID: 26802331
[No Abstract] [Full Text] [Related]
5. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
[TBL] [Abstract][Full Text] [Related]
6. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
7. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
[TBL] [Abstract][Full Text] [Related]
9. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
Lash JP; Ricardo AC; Roy J; Deo R; Fischer M; Flack J; He J; Keane M; Lora C; Ojo A; Rahman M; Steigerwalt S; Tao K; Wolf M; Wright JT; Go AS;
Am J Kidney Dis; 2016 Oct; 68(4):545-553. PubMed ID: 27209443
[TBL] [Abstract][Full Text] [Related]
10. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
11. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.
Rahman M; Xie D; Feldman HI; Go AS; He J; Kusek JW; Lash J; Miller ER; Ojo A; Pan Q; Seliger SL; Steigerwalt S; Townsend RR;
Am J Nephrol; 2014; 40(5):399-407. PubMed ID: 25401485
[TBL] [Abstract][Full Text] [Related]
12. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
13. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
[TBL] [Abstract][Full Text] [Related]
14. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.
Toth-Manikowski SM; Yang W; Appel L; Chen J; Deo R; Frydrych A; Krousel-Wood M; Rahman M; Rosas SE; Sha D; Wright J; Daviglus ML; Go AS; Lash JP; Ricardo AC;
Am J Kidney Dis; 2021 Aug; 78(2):200-209.e1. PubMed ID: 33857532
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
Viazzi F; Garneri D; Leoncini G; Gonnella A; Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Agabiti Rosei E; Deferrari G; Pontremoli R
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):921-7. PubMed ID: 24675005
[TBL] [Abstract][Full Text] [Related]
16. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
Chen J; Budoff MJ; Reilly MP; Yang W; Rosas SE; Rahman M; Zhang X; Roy JA; Lustigova E; Nessel L; Ford V; Raj D; Porter AC; Soliman EZ; Wright JT; Wolf M; He J;
JAMA Cardiol; 2017 Jun; 2(6):635-643. PubMed ID: 28329057
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
Lucove J; Vupputuri S; Heiss G; North K; Russell M
Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
[TBL] [Abstract][Full Text] [Related]
18. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
[TBL] [Abstract][Full Text] [Related]
19. Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project.
Guo Y; Apostalakis S; Blann AD; Lip GY
Cerebrovasc Dis; 2014; 38(3):204-11. PubMed ID: 25301077
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.
Cheng HT; Huang JW; Chiang CK; Yen CJ; Hung KY; Wu KD
J Clin Endocrinol Metab; 2012 Apr; 97(4):1268-76. PubMed ID: 22337909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
